The same structured methodology PE firms commission when evaluating acquisition targets—applied to your business, on your terms, to find and fix commercial gaps before someone else finds them.
When a PE firm considers acquiring a finserv technology company, they commission structured commercial due diligence across eight dimensions: market position, competitive moat, GTM execution, customer economics, digital presence, customer references, leadership depth, and pricing power.
Most finserv technology companies have never seen their business through this lens. They optimize for product-market fit, revenue growth, and customer satisfaction—but they don't know how an acquirer would score their competitive defensibility, customer economics durability, or pricing power. That gap between how you see your business and how PE evaluates it is where value gets left on the table—or where deals fall apart.
The PE Readiness Diagnostic closes that gap. It gives you the same structured assessment PE firms would commission, but on your timeline and with actionable improvement recommendations rather than a pass/fail verdict.
PE evaluation criteria differ from how most operators think about their business. The Diagnostic surfaces the dimensions PE firms weight most heavily.
PE firms care about NRR, churn cohort analysis, and customer concentration risk as much as top-line growth. The Diagnostic scores how durable your revenue actually is.
Having a differentiated product isn't the same as having a defensible one. The Diagnostic assesses switching costs, technical barriers, and how sustainable your advantages are over a 5-year hold.
Can your sales motion scale with capital behind it? PE firms evaluate channel mix, rep productivity, and AI readiness as predictors of post-investment growth acceleration.
The ability to raise prices without losing customers signals real value. The Diagnostic evaluates pricing model, competitive positioning, and expansion levers through a PE value creation lens.
The Diagnostic uses Gray Carroll's 8-workstream Commercial Viability Assessment methodology—the same framework PE firms commission for acquisition targets. The difference is framing: instead of a go/no-go investment recommendation, you get a PE Readiness Rating with a prioritized improvement roadmap.
How PE would score your TAM, growth trajectory, and right to win
Whether your advantages are defensible over a PE holding period
Can your sales motion scale with investment capital behind it
NRR, churn, CAC payback, LTV:CAC—the metrics PE weighs most heavily
Your G2/Gartner presence, review sentiment, and digital brand authority
What your customers actually say when the deal team asks
Executive bench depth and GTM leadership readiness for growth acceleration
Ability to capture more value through pricing model and expansion levers
Every Diagnostic produces a PE Readiness Rating based on your composite score, with specific actions for each workstream gap.
20–25 page assessment with workstream-level scoring and evidence-based findings
Your scores benchmarked against peer vendors in your sub-vertical
Prioritized actions ranked by impact and feasibility with timeline recommendations
Live walkthrough of findings, Q&A, and discussion of roadmap priorities
Three configurations to match your timeline, depth requirements, and where you are in your growth journey.
Quick commercial health check, board-level readiness snapshot
Pre-fundraise readiness, commercial strategy reset, board reporting
Sustained commercial improvement, PE-readiness programs, growth-stage companies
This isn't a generic GTM audit. The Diagnostic uses the same 8-workstream, scored methodology PE firms commission when evaluating finserv acquisition targets. You're seeing your business through the same lens an acquirer would use.
20+ years building GTM functions inside finserv technology companies (Nasdaq, DefenseStorm, investment management platforms). Not a generalist consultant learning your industry during the engagement.
Every Diagnostic includes a Commercial Improvement Roadmap with specific actions prioritized by impact and feasibility. You leave with a plan, not just a score.
They advise on general best practices. The Diagnostic scores you against PE investment criteria specifically calibrated for finserv technology.
Bankers tell you what to present. The Diagnostic tells you what to fix—before the presentation matters.
Internal teams see what they've built. The Diagnostic surfaces what an external evaluator with PE-calibrated scoring would find.
Gray Carroll serves both PE firms (with CVAs) and finserv vendors (with Diagnostics). To maintain the integrity both audiences depend on, we maintain a hard wall: we will never simultaneously run a Diagnostic for a vendor and a CVA on that same vendor for a PE client. The assessment must be independent to be credible. That's non-negotiable.
A PE Readiness Diagnostic is a structured commercial assessment that applies the same 8-workstream scoring methodology PE firms use when evaluating acquisition targets—but commissioned by the vendor to identify and strengthen commercial gaps proactively. It produces a scored assessment with a PE Readiness Rating (Strong / Moderate / Needs Work) and a prioritized improvement roadmap.
Most GTM consultants offer qualitative advice based on general frameworks. The PE Readiness Diagnostic uses the same quantified, scored methodology that PE firms actually commission during due diligence. You get the PE lens applied to your business—structured scoring across 8 commercial dimensions with specific, evidence-based findings and a prioritized improvement roadmap.
No. The Diagnostic identifies genuine commercial vulnerabilities and improvement opportunities that make your business stronger regardless of exit path. Companies that score well on PE evaluation criteria are companies with strong commercial execution—period. Whether you're preparing for a fundraise, facing competitive pressure, or simply want to operate at a higher level, the Diagnostic delivers actionable commercial intelligence.
A 20–25 page scored assessment with workstream-level findings, competitive benchmarking against peer vendors in your sub-vertical, a PE Readiness Rating (Strong / Moderate / Needs Work), and a prioritized Commercial Improvement Roadmap with specific actions ranked by impact and feasibility.
The methodology is calibrated for WealthTech, TAMP platforms, Investment Management, Banking Technology, RegTech, Cybersecurity for Financial Institutions, Alternative Investment platforms, Asset Allocators, and Fund Administration technology.
Diagnostic Express takes 5–7 business days covering 5 priority workstreams. Diagnostic Standard takes 2–3 weeks for a full 8-workstream assessment with competitive benchmarking. Diagnostic + Advisory takes 3–4 weeks plus ongoing quarterly reassessment.
Absolutely not. Diagnostic findings are confidential to the commissioning company. Gray Carroll maintains a hard wall between vendor Diagnostics and PE-commissioned CVAs. Your assessment is your competitive intelligence.
A 20-minute call to discuss where you are, what you're solving for, and whether the Diagnostic is the right fit. No pitch, no pressure—just a direct conversation about your commercial readiness.
Start a Conversation →